Advertisement

Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

By Ankit Agarwal

  • 20 Aug 2021
Premium
Emcure IPO to stick hefty price tag on pharma firm, hand 26% return to Bain

Pune-based Emcure Pharmaceuticals’ initial public offering (IPO) will make it the most expensive ...

This is a Premium article, Subscribe to read the full story!

Subscribe to avail up to 25% off* and get unlimited access to vccircle.com or start your 14 days free trial.

Advertisement
Advertisement